Tuesday, January 12, 2027 | 3:00 p.m. – 5:00 p.m.
Beyond the Deal: Navigating Patent, Trade Secret, and Technology Risks in Life Sciences Transactions
101 California Street, Suite 850, San Francisco, CA 94111
In today’s increasingly complex life sciences dealmaking environment, assessing IP risk requires looking well beyond a company’s patent portfolio. Whether licensing a biologic, acquiring a cell or gene therapy platform, or entering into a strategic collaboration, dealmakers must navigate a range of patent litigation, trade secret, and technology ownership risks that can significantly affect transaction value and long-term commercial success.
Join MoFo for a practical discussion of the litigation risks that can arise from life sciences transactions, including anticipated biosimilar competition, disputes over proprietary know-how, third-party patent rights, and ownership of critical technologies. Drawing on litigation experience and recent legal developments, the panel will explore common pitfalls, lessons learned from disputes, and strategies for identifying and mitigating IP risks.
Agenda
1:00
Opening Remarks & Legal Landscape
A high-level view of 2026 legislative trends.
1:15
Case Study: Intellectual Property in Federal Funding
Consequences of invention development under government agreements.
1:35
Patent Strategies in Government Contract Work
Unique IP considerations for special agreement types.
1:50
Live Q&A Session
Interactive session with our lead partners.
Featured Speakers